320 related articles for article (PubMed ID: 15259310)
21. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
Ahrén B
Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
[TBL] [Abstract][Full Text] [Related]
22. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
Creutzfeldt W
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
[TBL] [Abstract][Full Text] [Related]
23. [Glucagon-like peptide-1 (GLP-1) receptor].
Taminato T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():535-41. PubMed ID: 12238094
[No Abstract] [Full Text] [Related]
24. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use.
Byrne MM; Göke B
Diabet Med; 1996 Oct; 13(10):854-60. PubMed ID: 8911778
[TBL] [Abstract][Full Text] [Related]
25. The incretin notion and its relevance to diabetes.
Habener JF
Endocrinol Metab Clin North Am; 1993 Dec; 22(4):775-94. PubMed ID: 8125072
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective.
Nauck MA
Acta Diabetol; 1998 Oct; 35(3):117-29. PubMed ID: 9840447
[TBL] [Abstract][Full Text] [Related]
27. Incretin hormones and insulin secretion.
Ahrén B; Gromada J; Schmitz O
Horm Metab Res; 2004; 36(11-12):733-4. PubMed ID: 15655700
[No Abstract] [Full Text] [Related]
28. Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.
Meier JJ; Gallwitz B; Nauck MA
BioDrugs; 2003; 17(2):93-102. PubMed ID: 12641488
[TBL] [Abstract][Full Text] [Related]
29. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
Gromada J; Holst JJ; Rorsman P
Pflugers Arch; 1998 Apr; 435(5):583-94. PubMed ID: 9479010
[TBL] [Abstract][Full Text] [Related]
30. Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.
Hansotia T; Baggio LL; Delmeire D; Hinke SA; Yamada Y; Tsukiyama K; Seino Y; Holst JJ; Schuit F; Drucker DJ
Diabetes; 2004 May; 53(5):1326-35. PubMed ID: 15111503
[TBL] [Abstract][Full Text] [Related]
31. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
[TBL] [Abstract][Full Text] [Related]
32. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.
Li Y; Cao X; Li LX; Brubaker PL; Edlund H; Drucker DJ
Diabetes; 2005 Feb; 54(2):482-91. PubMed ID: 15677506
[TBL] [Abstract][Full Text] [Related]
33. [Gluco-incretin hormones in insulin secretion and diabetes].
Thorens B
Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
[TBL] [Abstract][Full Text] [Related]
34. Physiology of GLP-1--lessons from glucoincretin receptor knockout mice.
Thorens B
Horm Metab Res; 2004; 36(11-12):766-70. PubMed ID: 15655706
[TBL] [Abstract][Full Text] [Related]
35. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes.
Gautier JF; Fetita S; Sobngwi E; Salaün-Martin C
Diabetes Metab; 2005 Jun; 31(3 Pt 1):233-42. PubMed ID: 16142014
[TBL] [Abstract][Full Text] [Related]
36. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
[TBL] [Abstract][Full Text] [Related]
37. Extrapancreatic effects of GIP and GLP-1.
Vella A; Rizza RA
Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
[TBL] [Abstract][Full Text] [Related]
38. [The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus].
Escalada FJ
Med Clin (Barc); 2014 Sep; 143 Suppl 2():2-7. PubMed ID: 25437458
[TBL] [Abstract][Full Text] [Related]
39. GLP-1 in NIDDM.
Holst JJ
Diabet Med; 1996 Sep; 13(9 Suppl 6):S156-60. PubMed ID: 8894501
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide 1(GLP-1) in biology and pathology.
Meier JJ; Nauck MA
Diabetes Metab Res Rev; 2005; 21(2):91-117. PubMed ID: 15759282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
